Evidence map›Paper›PMID 42783868›Full record

ReviewJournal of imaging2026

Preclinical Imaging for the Translation of Innovative Nutritional Strategies: Current Applications and Future Perspectives.

Ippei Yamaoka

Abstract readReview
In one paragraph

Review in Journal of imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ippei YamaokaMedical Foods Research Institute, Otsuka Pharmaceutical Factory, Inc., Muya-cho, Naruto 772-8601, Japan.ORCID 0000-0003-0894-1748

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nutrient persistence, which manifests as residual deposits within parenteral and enteral delivery systems and as prolonged intraluminal retention in the gastrointestinal (GI) tract, represents a central determinant of safety and performance in clinical nutrition. This review integrates evidence across parenteral nutrition (PN), enteral nutrition (EN), and GI physiology to provide a comprehensive and mechanistic analysis of how nutrient residues arise and may affect clinically relevant outcomes among diverse nutrition delivery settings. Particular emphasis is placed on the role of imaging-based preclinical research in linking mechanistic observations of nutrient persistence with translational questions relevant to clinical nutrition. Traditional assessments of nutrient persistence have relied largely on indirect or bulk endpoints, limiting the ability to determine where nutrients remain, how long they persist, and how effectively they are cleared. Recent advances in fluorescence-based imaging provide spatially resolved and longitudinal approaches for assessing nutrient behavior in benchtop systems and preclinical models, revealing how transport dynamics and device geometry affect residue accumulation in PN systems, formulation rheology and thickener chemistry affect residue formation and microbial proliferation in EN delivery pathways, and physicochemical transformations and motility govern GI retention. This review synthesizes findings across these domains to establish an imaging-guided framework that links device engineering, formulation science, and physiological processes. Importantly, fluorescence-based imaging is presented in this review as a complementary approach rather than a replacement for established methods. Its translational value lies in its potential to generate measurable indicators of residue formation, clearance, and retention that may be linked to outcomes such as catheter performance, microbial proliferation, feeding tolerance, and nutrition delivery efficiency. Fluorescence-imaging supports the 3Rs (Replacement, Reduction, and Refinement) by enabling optimization in benchtop PN/EN models before animal studies and by allowing longitudinal assessment in GI animal models. Although challenges related to probe performance, standardization, and clinical validation remain, this approach positions nutrient persistence as a measurable and potentially modifiable parameter. Future research should prioritize standardized, outcome-linked preclinical imaging approaches that support clinical translation while promoting more efficient and responsible experimental design.

Indexed as

catheter flushingclinical nutrition systemsfeeding tubefluorescence imaginggastrointestinal transitmicrobial proliferationnutrition retentionoptical mappingpectinresidual lipid emulsion

Identifiers

PMID42783868
PMCPMC13608515

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.